Focus On Regulation

European Medicines Agency’s new guide on the wording of therapeutic indication

On 21 October 2019, the European Medicines Agency (EMA) published a guide for assessors of centralised applications for marketing authorisation. The guide focuses on the wording used in...

Read more Share

Heads of Medicines Agencies publishes practical guidance on nitrosamines

In late October 2019, the Co-ordination Group for Mutual Recognition and Decentralised procedures – Human (CMDh) of the Heads of Medicines Agencies (HMA) published a practical...

Read more Share

Germany’s proposed digital antitrust law: an ambitious project to regulate digital markets

Germany is about to implement an ambitious new "digital antitrust law" (GWB-Digitalisierungsgesetz) to effectively regulate online markets. The draft Ministerial bill on the 10th amendment...

Read more Share

What the European Medicines Agency’s qualification opinion means for electronic clinical data capture

The European Medicines Agency (EMA) issued a qualification opinion following a request concerning proprietary eSource DDC (Direct Data Capture) technology. This technology allows the...

Read more Share

Publication of further guidance on the role of the “UK Responsible Person” in case of no-deal Brexit

On 18 September 2019, the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) published new guidance regarding the role and responsibilities of the “UK...

Read more Share
Loading data